IBB

Featured

Biotech ETFs Feeling the Winds of Change

By Tom LydonJuly 26, 2010

Featured

5 Biotech ETFs If You’re Bullish

By Tom LydonJune 25, 2010

Featured

Biotech’s ‘Super Bowl’ Could Spark a Biotech ETF Run

By Tom LydonJune 4, 2010

Featured

What to Look for in Health Care ETFs

By Tom LydonApril 21, 2010

Featured

Biotech ETFs to Watch As Patent Reform Bill Heats Up

By Tom LydonApril 15, 2010

Featured

Health Care Reform ETF Winners and Losers

By Tom LydonApril 5, 2010

Featured

Biotech ETFs for Any Risk Appetite

By Tom LydonMarch 11, 2010

Featured

Biotechnology M&As, Wholesale Mix the Markets and ETFs

By Tom LydonMarch 10, 2010

Featured

Why ETFs Are the Way to Play Biotechnology

By Tom LydonMarch 3, 2010

Featured

Biotech ETFs: Where the Future Lies

By Tom LydonFebruary 5, 2010

Featured

Biotech ETFs: More Acquisitions and Specialized Drugs

By Tom LydonJanuary 13, 2010

Featured

Choosing the Best Biotechnology ETF for You

By Tom LydonJanuary 3, 2010

Featured

Which ETFs Were Spurned By the Health Care Bill?

By Tom LydonDecember 22, 2009

Featured

ETFs to Play Obama’s New Policies

By Tom LydonNovember 13, 2009

Alternative ETFs

5 ETF Themes Investors Can Consider

By Tom LydonOctober 6, 2009

Featured

7 Reasons Biotechnology ETFs Could Succeed

By Tom LydonAugust 6, 2009

Featured

Biotech Sector and ETFs Get a Lifeline

By Tom LydonJuly 8, 2009

Alternative ETFs

5 Ways ETF Investors Can Offset Emerging Market Risk

By Tom LydonJuly 2, 2009

Previous 1 … 20 21 22 23 Next